Citeline Introduces Global Patient Insights
May 15 2024 - 9:00AM
Citeline announces the launch of Global Patient Insights, the
industry’s most comprehensive view of the worldwide patient
landscape, designed to optimize the site selection process for
clinical trial sponsors.
Global Patient Insights seamlessly integrates real-world data on
patient population and diversity with Sitetrove’s best-in-class
site and investigator intelligence. This robust RWD dataset
includes global electronic health records, census and epidemiology
data, along with U.S. social determinants of health (SDOH) and
medical claims data.
The race to develop a COVID-19 vaccine underscored the
importance of diversity in clinical trials. Despite efforts to
improve trial diversity by regulatory agencies, including the U.S.
Food and Drug Administration and the European Medicines Agency,
clinical trials still lack representation among key racial and
ethnic minority groups.
With Global Patient Insights, study sponsors will be able to
easily locate sites with clinically relevant and diverse patient
populations by:
- Prioritizing countries and global sites with
higher volumes of clinically relevant patient
populations
- Identifying U.S. physicians near investigators with access
to the right patients for referrals
- Visualizing patient populations via dynamic dashboards
and heatmaps
“Global Patient Insights takes Sitetrove to an exciting new
level,” says Christina Masturzo, Citeline Vice President, Product
Management. “For sponsors, it’s the best of both worlds: our
gold-standard Sitetrove data, coupled with information-rich
real-world data. In fact, our product team refers to it as
‘Sitetrove on steroids.'
"Our goal at Citeline is to get the right treatments to the
right patients at the right time. We do this by guiding sponsors
throughout the drug development life cycle, from study design and
protocol development through to site selection, patient recruitment
and, ultimately, enrollment.”
Learn more about Citeline’s Global Patient Insights at
Citeline.com.
About Citeline Citeline, a Norstella
company, powers a full suite of complementary business intelligence
offerings to meet the evolving needs of life science professionals
to accelerate the connection of treatments to patients and patients
to treatments. These patient-focused solutions and services deliver
and analyze data used to drive clinical, commercial, and
regulatory-related decisions and create real-world opportunities
for growth.
Citeline’s global teams of analysts, journalists, and
consultants keep their fingers on the pulse of the pharmaceutical,
biomedical and medtech industries, covering them with expert
insights: key diseases, clinical trials, drug R&D and
approvals, market forecasts, and more. For more information on one
of the world’s most trusted health science partners,
visit Citeline and follow on LinkedIn and X.
Citeline PR contact: Diffusion PR for
Citelineciteline@diffusionpr.com (213) 318-4500